Scan to Download
One power score. Smarter investment decisions
Mira Pharmaceuticals Inc
MIRA1.250USD
-0.020-1.57%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
21.73MMarket Cap
LossP/E TTM
Mira Pharmaceuticals Inc
1.250
-0.020-1.57%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q1
FY2021Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
7.44%-799.65K
-55.31%-1.63M
-74.40%-1.81M
-4.59%-1.84M
-30.74%-863.93K
2.40%-1.05M
---1.04M
---1.76M
---660.81K
47.35%-1.08M
-12337.16%-2.04M
---16.42K
Net income from continuing operations
9.08%-1.54M
-3.84%-1.78M
58.54%-2.40M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
---5.79M
---3.59M
---1.27M
9.08%-1.34M
-2488.94%-1.48M
---56.98K
Other non-cash items
----
----
----
----
----
----
--250.00K
--439.38K
--292.92K
----
----
----
Change in working capital
11.64%248.50K
-529.14%-721.06K
-94.10%47.88K
-68.87%-67.25K
152.03%222.59K
44.49%168.03K
--811.74K
---39.83K
---427.79K
120.35%116.28K
-1703.58%-571.37K
--35.63K
-Change in receivables
----
----
100.00%0.00
--0.00
--0.00
--11.86K
---11.86K
----
----
----
----
----
-Change in prepaid expenses
-26.73%56.21K
-277.68%-103.88K
177.69%31.84K
113.76%22.05K
338.19%76.71K
197.39%58.47K
---40.98K
---160.29K
--17.51K
---60.03K
----
----
-Change in payables and accrued expense
31.81%192.28K
-731.72%-617.18K
-96.45%30.52K
-174.13%-89.31K
132.76%145.88K
-44.59%97.70K
--859.09K
--120.47K
---445.30K
131.16%176.32K
-1688.14%-565.87K
--35.63K
-Change in other current assets
----
----
----
----
----
----
--5.50K
--0.00
--0.00
100.00%0.00
---5.50K
--0.00
Cash from non-recurring investing activities
Cash from operating activities
7.44%-799.65K
-55.31%-1.63M
-74.40%-1.81M
-4.59%-1.84M
-30.74%-863.93K
2.40%-1.05M
---1.04M
---1.76M
---660.81K
47.35%-1.08M
-12337.16%-2.04M
---16.42K
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
103.65%323.84K
113.89%3.38K
313.83%493.40K
-58.41%3.16M
-76.76%159.01K
-103.35%-24.34K
---230.75K
--7.60M
--684.29K
-46.47%725.68K
7926.07%1.36M
--16.89K
Net cash flow from debt Issuance/repayment
----
----
----
---14.47K
----
-100.00%0.00
--1.14M
--0.00
---219.54K
272.96%86.48K
-225.00%-50.00K
--40.00K
Net cash flow from common stock issuance/repurchase
--345.32K
--3.38K
136.55%493.40K
-65.44%3.13M
----
----
---1.35M
--9.05M
--0.00
-100.00%0.00
--1.58M
--0.00
Net cash flow from other financing activities
-113.51%-21.48K
----
100.00%0.00
103.29%47.74K
-82.41%159.01K
-103.81%-24.34K
---19.15K
---1.45M
--903.83K
458.62%639.20K
-671.32%-178.24K
---23.11K
Net cash from non-recurrent financing activities
Net cash from financing activities
103.65%323.84K
113.89%3.38K
313.83%493.40K
-58.41%3.16M
-76.76%159.01K
-103.35%-24.34K
---230.75K
--7.60M
--684.29K
-46.47%725.68K
7926.07%1.36M
--16.89K
Net cash flow
Beginning cash balance
-65.81%1.21M
-38.45%2.83M
-29.37%4.14M
11275.66%2.82M
261478.58%3.53M
1211.35%4.60M
--5.87M
--24.82K
--1.35K
-87.51%350.98K
80379.86%2.81M
--3.49K
Current period cash flow changes
32.50%-475.81K
-51.47%-1.63M
-3.62%-1.31M
-77.40%1.32M
-3102.96%-704.91K
-207.15%-1.07M
---1.27M
--5.84M
--23.47K
49.09%-349.63K
-146537.31%-686.79K
--469.00
Ending cash balance
-74.13%730.48K
-65.81%1.21M
-38.45%2.83M
-29.37%4.14M
11275.66%2.82M
261478.58%3.53M
--4.60M
--5.87M
--24.82K
-99.94%1.35K
53505.08%2.12M
--3.96K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
